Back to Journals » OncoTargets and Therapy » Volume 13

Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway

Total article views   HTML views PDF downloads Totals
5,487 Dovepress* 4,864+ 730 5,594
PubMed Central* 623 151 774
Totals 5,487 881 6,368
*Since 2 October 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar